Integrated Wealth Concepts’s BioMarin Pharmaceuticals BMRN Stock Holding History

Integrated Wealth Concepts’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.81M	Sell	84,046 -1,401	-2%	-$76.7K	0.03%	497
2026 Q1	$4.83M	Buy	85,447 +71,792	+526%	+$4.19M	0.04%	434
2025 Q4	$812K	Sell	13,655 -835	-6%	-$45.5K	0.01%	867
2025 Q3	$785K	Buy	14,490 +5,078	+54%	+$290K	0.01%	1112
2025 Q2	$517K	Buy	+9,412	New	+$554K	0.01%	1255
2024 Q2	–	Sell	-3,097	Closed	-$270K	–	1652
2024 Q1	$270K	Buy	3,097 +18	+0.6%	+$1.61K	﹤0.01%	1377
2023 Q4	$297K	Sell	3,079 -26	-0.8%	-$2.3K	﹤0.01%	1277
2023 Q3	$275K	Buy	3,105 +622	+25%	+$55.3K	﹤0.01%	1272
2023 Q2	$215K	Buy	+2,483	New	+$234K	﹤0.01%	1388

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Integrated Wealth Concepts's BMRN Position: Q2 2026 in Review

Integrated Wealth Concepts reduced its BioMarin Pharmaceuticals (BMRN) stake by 1.6% in Q2 2026, selling an estimated $76.7K and leaving 84,046 shares worth $4.81M. The position accounts for 0.03% of the portfolio, ranked #497.

Integrated Wealth Concepts first reported a position in BMRN in Q2 2023 and has held it in 9 quarters since. The position peaked at $4.83M in Q1 2026. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Integrated Wealth Concepts held 84,046 shares of BioMarin Pharmaceuticals worth $4.81M as of Q2 2026.
Integrated Wealth Concepts sold 1,401 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $76.7K.
BioMarin Pharmaceuticals made up 0.03% of Integrated Wealth Concepts's portfolio in Q2 2026, its #497 holding.
Integrated Wealth Concepts first reported a position in BioMarin Pharmaceuticals in Q2 2023 and has held it in 9 quarters since.
Integrated Wealth Concepts's BioMarin Pharmaceuticals position peaked at $4.83M in Q1 2026.
565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.